BCL2 and colorectal carcinoma: We demonstrated, for the first time, that lncRNA—UCA1 accelerates proliferation and induces 5‐fluorouracil (5‐FU) resistance in CRC through binding to miR‐204‐5p and then increasing the expression of its targets (CREB1, BCL2, and RAB22A).28